RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,628,071.51

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$57.07

▲ +0.6 (1.06%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

From Weiss Ratings | Ad

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/14/2024	Stephen Michael Kelsey	Insider	Sell	16,666	$49.49	$824,800.34	264,408
10/11/2024	Jack Anders	CFO	Sell	10,000	$50.30	$503,000.00	98,932
10/11/2024	Jeff Cislini	General Counsel	Sell	6,000	$50.17	$301,020.00	45,634
10/11/2024	Margaret A. Horn	COO	Sell	50,000	$50.34	$2,517,000.00	132,320
10/11/2024	Mark A. Goldsmith	Insider	Sell	30,000	$50.36	$1,510,800.00	300,170
10/8/2024	Barbara Weber	Director	Sell	5,200	$48.02	$249,704.00	13,065
10/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$44.93	$449,300.00	300,170
8/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$45.88	$458,800.00	311,885
7/15/2024	Stephen Michael Kelsey	Insider	Sell	16,667	$46.47	$774,515.49	269,073
7/12/2024	Mark A. Goldsmith	Insider	Sell	25,000	$45.05	$1,126,250.00	311,885
7/9/2024	Jeff Cislini	General Counsel	Sell	2,399	$40.83	$97,951.17	47,088
7/9/2024	Sushil Patel	Director	Sell	2,155	$44.00	$94,820.00	19,948
6/26/2024	Jeff Cislini	General Counsel	Sell	2,000	$38.47	$76,940.00	49,487
6/24/2024	Stephen Michael Kelsey	Insider	Sell	200	$39.00	$7,800.00	269,073
5/3/2024	Jack Anders	CFO	Sell	10,000	$40.03	$400,300.00	101,959
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513
10/16/2023	Margaret A. Horn	COO	Sell	25,000	$33.95	$848,750.00	96,960
10/11/2023	Stephen Michael Kelsey	Insider	Sell	16,667	$29.05	$484,176.35	273,721
9/28/2023	Jeff Cislini	General Counsel	Sell	2,000	$28.20	$56,400.00	40,013
9/18/2023	Jack Anders	CFO	Sell	1,427	$31.31	$44,679.37	53,667
9/18/2023	Jeff Cislini	General Counsel	Sell	1,214	$31.31	$38,010.34	42,013
9/18/2023	Margaret A. Horn	COO	Sell	2,514	$31.31	$78,713.34	96,960
9/18/2023	Stephen Michael Kelsey	Insider	Sell	2,060	$31.31	$64,498.60	290,388
9/15/2023	Margaret A. Horn	COO	Sell	5,000	$32.08	$160,400.00	99,474
9/1/2023	Barbara Weber	Director	Sell	15,000	$35.07	$526,050.00	15,825
9/1/2023	Jack Anders	CFO	Sell	20,000	$35.05	$701,000.00	55,094
9/1/2023	Mark A. Goldsmith	Insider	Sell	30,000	$35.05	$1,051,500.00	357,386
8/31/2023	Margaret A. Horn	COO	Sell	10,000	$34.05	$340,500.00	99,474
8/15/2023	Margaret A. Horn	COO	Sell	5,000	$30.53	$152,650.00	99,474
8/1/2023	Stephen Michael Kelsey	Insider	Sell	16,666	$29.19	$486,480.54	309,114
7/31/2023	Jeff Cislini	General Counsel	Sell	1,500	$26.02	$39,030.00	43,227
6/20/2023	Jack Anders	CFO	Sell	1,249	$24.89	$31,087.61	55,094
6/20/2023	Jeff Cislini	General Counsel	Sell	1,239	$25.14	$31,148.46	44,727
6/20/2023	Stephen Michael Kelsey	Insider	Sell	2,102	$24.89	$52,318.78	325,780
3/17/2023	Jack Anders	CFO	Sell	665	$21.78	$14,483.70	55,233
3/17/2023	Margaret A. Horn	Insider	Sell	1,230	$21.78	$26,789.40	100,062
3/10/2023	Thilo Schroeder	Director	Buy	100,000	$20.46	$2,046,000.00	1,553,134
3/7/2023	Thilo Schroeder	Director	Buy	550,000	$22.00	$12,100,000.00	1,453,134
12/19/2022	Jack Anders	CFO	Sell	658	$22.94	$15,094.52	29,298
12/19/2022	Xiaolin Wang	Insider	Sell	708	$22.94	$16,241.52	30,527
10/31/2022	Margaret A. Horn	COO	Sell	17,767	$20.41	$362,624.47	17,767
10/26/2022	Margaret A. Horn	Insider	Sell	17,768	$20.15	$358,025.20	35,534
9/19/2022	Jack Anders	CFO	Sell	449	$19.04	$8,548.96	29,956
9/19/2022	Xiaolin Wang	Insider	Sell	735	$19.04	$13,994.40	31,235
7/22/2022	Lorence H. Kim	Director	Buy	50,000	$20.00	$1,000,000.00	60,500
6/17/2022	Xiaolin Wang	Insider	Sell	665	$17.75	$11,803.75	31,970
6/8/2022	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	419,901	$20.25	$8,502,995.25	5,104,130
3/28/2022	Thilo Schroeder	Director	Buy	725	$24.71	$17,914.75
3/25/2022	Thilo Schroeder	Director	Buy	42,000	$24.79	$1,041,180.00
3/23/2022	Thilo Schroeder	Director	Buy	53,118	$23.72	$1,259,958.96
3/21/2022	Thilo Schroeder	Director	Buy	75,731	$20.74	$1,570,660.94
3/18/2022	Thilo Schroeder	Director	Buy	82,200	$20.30	$1,668,660.00
3/17/2022	Margaret A. Horn	Insider	Sell	321	$18.61	$5,973.81
3/11/2022	Thilo Schroeder	Director	Buy	3,110	$20.93	$65,092.30
3/9/2022	Thilo Schroeder	Director	Buy	39,600	$20.07	$794,772.00
3/7/2022	Thilo Schroeder	Director	Buy	103,005	$18.39	$1,894,261.95
3/4/2022	Thilo Schroeder	Director	Buy	56,300	$17.69	$995,947.00
3/2/2022	Thilo Schroeder	Director	Buy	116,290	$18.94	$2,202,532.60
2/18/2022	Thilo Schroeder	Director	Buy	400,000	$17.00	$6,800,000.00
2/8/2022	Thilo Schroeder	Director	Buy	300,000	$45.00	$13,500,000.00
12/17/2021	Jack Anders	Insider	Sell	170	$24.41	$4,149.70

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

From Weiss Ratings | Ad

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	3,627,025	$164.52M	0.0%	+8.7%	2.156%
11/15/2024	Barclays PLC	294,664	$13.36M	0.0%	+187.1%	0.175%
11/15/2024	Nomura Asset Management Co. Ltd.	2,064	$94K	0.0%	-22.3%	0.001%
11/15/2024	Y Intercept Hong Kong Ltd	5,444	$0.25M	0.0%	N/A	0.003%
11/15/2024	Wellington Management Group LLP	11,401,394	$517.05M	0.1%	-16.5%	6.778%
11/15/2024	State Street Corp	5,279,584	$239.43M	0.0%	+4.1%	3.138%
11/15/2024	Quarry LP	1,800	$82K	0.0%	N/A	0.001%
11/15/2024	Point72 DIFC Ltd	9,312	$0.42M	0.0%	N/A	0.006%
11/15/2024	Polar Asset Management Partners Inc.	23,700	$1.08M	0.0%	+21.5%	0.014%
11/15/2024	Janus Henderson Group PLC	6,137,244	$278.28M	0.1%	+32.3%	3.648%
11/15/2024	HighVista Strategies LLC	55,562	$2.52M	0.9%	+38.6%	0.033%
11/15/2024	Holocene Advisors LP	2,149,561	$97.48M	0.4%	-2.4%	1.278%
11/15/2024	Cinctive Capital Management LP	53,361	$2.42M	0.1%	+132.7%	0.032%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	3,430	$0.16M	0.0%	-42.5%	0.002%
11/15/2024	Erste Asset Management GmbH	27,400	$1.21M	0.0%	N/A	0.016%
11/14/2024	Bellevue Group AG	4,871,360	$220.92M	3.6%	-3.1%	2.896%
11/14/2024	Edgestream Partners L.P.	38,482	$1.75M	0.1%	N/A	0.023%
11/14/2024	Fred Alger Management LLC	540,673	$24.52M	0.1%	+2,384.3%	0.321%
11/14/2024	Eventide Asset Management LLC	523,051	$23.72M	0.4%	-19.6%	0.311%
11/14/2024	Verition Fund Management LLC	14,226	$0.65M	0.0%	N/A	0.008%
11/14/2024	Captrust Financial Advisors	8,459	$0.38M	0.0%	+4.1%	0.005%
11/14/2024	Walleye Capital LLC	323,732	$14.68M	0.0%	+44.4%	0.192%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	216,026	$9.80M	0.0%	-10.5%	0.128%
11/14/2024	Ally Bridge Group NY LLC	163,500	$7.42M	4.0%	N/A	0.097%
11/14/2024	Acuta Capital Partners LLC	108,000	$4.90M	4.0%	-18.8%	0.064%
11/14/2024	MetLife Investment Management LLC	86,411	$3.92M	0.0%	-1.7%	0.051%
11/13/2024	Finepoint Capital LP	731,960	$33.19M	2.4%	+0.3%	0.435%
11/13/2024	Advantage Alpha Capital Partners LP	10,164	$0.46M	0.1%	N/A	0.006%
11/13/2024	FMR LLC	5,875,893	$266.47M	0.0%	+4.4%	3.493%
11/13/2024	The Manufacturers Life Insurance Company	212,841	$9.65M	0.0%	+0.2%	0.127%
11/12/2024	Citigroup Inc.	117,938	$5.35M	0.0%	+29.5%	0.070%
11/12/2024	Eagle Asset Management Inc.	72,030	$3.27M	0.0%	N/A	0.043%
11/12/2024	Charles Schwab Investment Management Inc.	1,763,117	$79.96M	0.0%	+58.9%	1.048%
11/9/2024	Intech Investment Management LLC	37,694	$1.71M	0.0%	N/A	0.023%
11/8/2024	Citizens Financial Group Inc. RI	26,792	$1.22M	0.0%	-6.2%	0.016%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	26,901	$1.22M	0.0%	N/A	0.016%
11/7/2024	Swiss National Bank	225,531	$10.23M	0.0%	-0.6%	0.135%
11/6/2024	CIBC Asset Management Inc	4,767	$0.22M	0.0%	N/A	0.003%
11/6/2024	KBC Group NV	3,221	$0.15M	0.0%	+12.9%	0.002%
11/5/2024	Victory Capital Management Inc.	437,750	$19.85M	0.0%	-19.3%	0.262%
11/4/2024	Los Angeles Capital Management LLC	7,228	$0.33M	0.0%	-3.0%	0.004%
11/4/2024	State of New Jersey Common Pension Fund D	48,184	$2.19M	0.0%	-5.6%	0.029%
10/31/2024	Principal Financial Group Inc.	12,947	$0.59M	0.0%	-46.5%	0.008%
10/28/2024	US Bancorp DE	2,455	$0.11M	0.0%	-16.8%	0.001%
10/25/2024	China Universal Asset Management Co. Ltd.	32,127	$1.46M	0.2%	+65.7%	0.019%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	6,041	$0.27M	0.0%	+22.6%	0.004%
10/23/2024	Values First Advisors Inc.	2,043	$93K	0.1%	N/A	0.001%
10/19/2024	Allspring Global Investments Holdings LLC	38,589	$1.75M	0.0%	+1,109.7%	0.023%
10/18/2024	Raymond James & Associates	190,505	$8.64M	0.0%	+156.2%	0.114%
10/16/2024	Vontobel Holding Ltd.	5,432	$0.25M	0.0%	N/A	0.003%
10/11/2024	Creative Planning	37,868	$1.72M	0.0%	+40.1%	0.023%
10/10/2024	Exchange Traded Concepts LLC	3,760	$0.17M	0.0%	-44.7%	0.002%
10/9/2024	Wedmont Private Capital	47,600	$2.25M	0.1%	-4.0%	0.028%
10/7/2024	GAMMA Investing LLC	620	$28K	0.0%	+55.8%	0.000%
10/5/2024	Handelsbanken Fonder AB	46,775	$2.12M	0.0%	+27.5%	0.028%
10/5/2024	Halpern Financial Inc.	5,626	$0.26M	0.1%	N/A	0.003%
10/3/2024	SG Americas Securities LLC	31,454	$1.43M	0.0%	+193.1%	0.019%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	5,966	$0.23M	0.0%	N/A	0.004%
8/26/2024	Teachers Retirement System of The State of Kentucky	31,410	$1.22M	0.0%	-16.0%	0.019%
8/19/2024	Point72 Asset Management L.P.	227,922	$8.85M	0.0%	N/A	0.136%
8/16/2024	Creative Planning	27,029	$1.05M	0.0%	+65.2%	0.016%
8/16/2024	Algert Global LLC	40,048	$1.55M	0.1%	+519.9%	0.024%
8/15/2024	Susquehanna Fundamental Investments LLC	228,513	$8.87M	0.2%	+10.7%	0.137%
8/15/2024	The Manufacturers Life Insurance Company	212,368	$8.24M	0.0%	+6.7%	0.127%
8/15/2024	AQR Capital Management LLC	12,832	$0.50M	0.0%	N/A	0.008%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	5,966	$0.23M	0.0%	N/A	0.004%
8/14/2024	Fred Alger Management LLC	21,764	$0.85M	0.0%	N/A	0.013%
8/14/2024	Marshall Wace LLP	816,055	$31.67M	0.0%	-46.9%	0.489%
8/14/2024	Logos Global Management LP	1,200,000	$46.57M	3.7%	N/A	0.727%
8/14/2024	Farallon Capital Management LLC	9,757,692	$378.70M	1.8%	+30.0%	5.842%
8/14/2024	Xponance Inc.	9,651	$0.38M	0.0%	+13.9%	0.006%
8/14/2024	Integral Health Asset Management LLC	325,000	$12.61M	1.2%	-22.6%	0.195%
8/14/2024	Hood River Capital Management LLC	914,003	$35.47M	0.7%	N/A	0.547%
8/14/2024	HighVista Strategies LLC	40,083	$1.56M	0.6%	+179.8%	0.024%
8/14/2024	ProShare Advisors LLC	28,868	$1.12M	0.0%	-21.1%	0.017%
8/14/2024	Profund Advisors LLC	35,999	$1.40M	0.1%	-21.9%	0.022%
8/13/2024	Ensign Peak Advisors Inc	269,504	$10.46M	0.0%	+577.4%	0.163%
8/13/2024	Sei Investments Co.	45,149	$1.75M	0.0%	+175.8%	0.027%
8/13/2024	Public Employees Retirement Association of Colorado	13,423	$0.52M	0.0%	-1.9%	0.008%
8/12/2024	XTX Topco Ltd	23,717	$0.92M	0.1%	N/A	0.014%
8/12/2024	Seven Eight Capital LP	69,602	$2.70M	0.3%	+1.6%	0.042%
8/12/2024	Hsbc Holdings PLC	14,913	$0.57M	0.0%	-91.1%	0.009%
8/12/2024	Amalgamated Bank	5,272	$0.21M	0.0%	+7.4%	0.003%
8/12/2024	E Fund Management Co. Ltd.	11,274	$0.44M	0.0%	-16.1%	0.007%
8/10/2024	Sofinnova Investments Inc.	455,099	$17.66M	0.9%	N/A	0.276%
8/9/2024	Citizens Financial Group Inc. RI	28,562	$1.11M	0.0%	N/A	0.017%
8/9/2024	Dimensional Fund Advisors LP	390,583	$15.16M	0.0%	-70.7%	0.237%
8/8/2024	First Turn Management LLC	329,519	$12.79M	2.1%	N/A	0.200%
8/8/2024	Nicholas Investment Partners LP	158,132	$6.14M	0.6%	N/A	0.096%
8/8/2024	American Century Companies Inc.	519,305	$20.15M	0.0%	N/A	0.315%
8/8/2024	State of New Jersey Common Pension Fund D	51,045	$1.98M	0.0%	-44.4%	0.031%
8/6/2024	Great Lakes Advisors LLC	120,867	$4.69M	0.0%	-58.2%	0.073%
8/6/2024	Los Angeles Capital Management LLC	7,451	$0.29M	0.0%	-17.4%	0.005%
8/6/2024	Candriam S.C.A.	554,334	$21.51M	0.1%	-5.1%	0.336%
8/5/2024	Arizona State Retirement System	32,273	$1.25M	0.0%	+15.6%	0.020%
8/5/2024	Victory Capital Management Inc.	542,601	$21.06M	0.0%	-9.7%	0.329%
8/3/2024	TD Asset Management Inc	250,194	$9.71M	0.0%	-1.7%	0.152%
8/2/2024	Alphabet Inc.	5,307,075	$205.97M	10.4%	+0.1%	3.217%
8/1/2024	Rhumbline Advisers	228,567	$8.87M	0.0%	+9.2%	0.139%
7/29/2024	Principal Financial Group Inc.	24,222	$0.94M	0.0%	-19.9%	0.015%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $57.07

$56.01

$57.97

50 Day Range

MA: $49.99

$41.97

$60.60

52 Week Range

Now: $57.07

$20.51

$62.40

Volume

843,096 shs

Average Volume

1,336,532 shs

Market Capitalization

$9.60 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Margaret A Horn (Insider)
Jeff Cislini (General Counsel)
Xiaolin Wang (Insider)
Sushil Patel (Director)
Barbara Weber (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Wellington Management Group LLP — 6.78%
Janus Henderson Group PLC — 3.65%
FMR LLC — 3.49%
State Street Corp — 3.14%
Bellevue Group AG — 2.90%
Geode Capital Management LLC — 2.16%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are selling Revolution Medicines stock?: Within the last quarter, RVMD stock was sold by these institutional investors:
Wellington Management Group LLP
Bellevue Group AG
Eventide Asset Management LLC
Victory Capital Management Inc.
Holocene Advisors LP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Acuta Capital Partners LLC
Principal Financial Group Inc.
In the last year, company insiders that have sold Revolution Medicines company stock include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Margaret A Horn (Insider)
Jeff Cislini (General Counsel)
Learn More investors selling Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: In the last quarter, RVMD stock was purchased by institutional investors including:
Janus Henderson Group PLC
Charles Schwab Investment Management Inc.
Fred Alger Management LLC
Geode Capital Management LLC
FMR LLC
Jane Street Group LLC
State Street Corp
Barclays PLC